These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19431241)

  • 1. [Depressive disorders in patients after stroke].
    Gusev EI; Bogolepova AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; Suppl 22():10-5. PubMed ID: 19431241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressive disorders in stroke patients.
    Gusev EI; Bogolepova AN
    Neurosci Behav Physiol; 2009 Sep; 39(7):639-43. PubMed ID: 19621267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division.
    Pasquini M; Biondi M; Costantini A; Cairoli F; Ferrarese G; Picardi A; Sternberg C
    Depress Anxiety; 2006; 23(7):441-8. PubMed ID: 16841345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant therapy in post-stroke depression.
    Starkstein SE; Mizrahi R; Power BD
    Expert Opin Pharmacother; 2008 Jun; 9(8):1291-8. PubMed ID: 18473704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression.
    Bech P; Tanghøj P; Andersen HF; Overø K
    Psychopharmacology (Berl); 2002 Aug; 163(1):20-5. PubMed ID: 12185396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Where is the room for improvement in the drug treatment of depression and anxiety?
    Baldwin DS
    Hum Psychopharmacol; 2011 Jan; 26(1):1-3. PubMed ID: 23055413
    [No Abstract]   [Full Text] [Related]  

  • 7. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G; Beeské S; Stahl SM
    J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo onset of Parkinson's disease after antidepressant treatment with citalopram.
    Stadtland C; Erfurth A; Arolt V
    Pharmacopsychiatry; 2000 Sep; 33(5):194-5. PubMed ID: 11071022
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action.
    Andreasen JT; Fitzpatrick CM; Larsen M; Skovgaard L; Nielsen SD; Clausen RP; Troelsen K; Pickering DS
    Brain Res; 2015 Mar; 1601():117-26. PubMed ID: 25578259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global cognitive level and antidepressant efficacy in post-stroke depression.
    Spalletta G; Caltagirone C
    Psychopharmacology (Berl); 2004 Sep; 175(2):262-3; author reply 264. PubMed ID: 15365687
    [No Abstract]   [Full Text] [Related]  

  • 11. The presence of depression and anxiety in Parkinson's disease.
    Mercury MG; Tschan W; Kehoe R; Kuechler A
    Dis Mon; 2007 May; 53(5):296-301. PubMed ID: 17656191
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis.
    Chen Y; Guo JJ; Zhan S; Patel NC
    Ann Pharmacother; 2006 Dec; 40(12):2115-22. PubMed ID: 17119102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive improvement after treatment of depressive symptoms in the acute phase of stroke.
    Simis S; Nitrini R
    Arq Neuropsiquiatr; 2006 Jun; 64(2B):412-7. PubMed ID: 16917611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral agent entecavir exacerbates major depression.
    Pai MS; Yang SN; Lin JC; Shiah IS
    Psychiatry Clin Neurosci; 2013 Jul; 67(5):364-5. PubMed ID: 23859667
    [No Abstract]   [Full Text] [Related]  

  • 15. Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue.
    Karaiskos D; Tzavellas E; Spengos K; Vassilopoulou S; Paparrigopoulos T
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):349-53. PubMed ID: 23037649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citalopram-associated clitoral priapism: a case series.
    Berk M; Acton M
    Int Clin Psychopharmacol; 1997 Mar; 12(2):121-2. PubMed ID: 9219048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of benzodiazepines in the treatment of depression].
    Escande M; Granier F; Girard M
    Encephale; 1983; 9(4 Suppl 2):273B-277B. PubMed ID: 6144524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Citalopram and desmethylcitalopram for psychiatric patients].
    Linnet K; Olesen OV
    Ugeskr Laeger; 1996 Aug; 158(35):4920-3. PubMed ID: 8801700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citalopram therapy as a risk factor for symptomatic hyponatremia caused by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): a case report.
    Miehle K; Paschke R; Koch CA
    Pharmacopsychiatry; 2005 Jul; 38(4):181-2. PubMed ID: 16025423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial.
    Bech P; Fava M; Trivedi MH; Wisniewski SR; Rush AJ
    Acta Psychiatr Scand; 2012 Apr; 125(4):342-8. PubMed ID: 22077211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.